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FREQUENCY OF  B LYMPHOCYTES RESPONSIVE  
TO ANTI - IMMUNOGLOBUL IN  
By ANTHONY L. DEFRANCO,* ELIZABETH S. RAVECHE, RICHARD ASOFSKY, 
AND WILLIAM E. PAUL 
From the Laborato(y of Immunology and the Laboratory of Microbial Immunity, National Institute of Allergy 
and Infectious Diseases, and the Laboratory of Experimental Pathology, National Institute of Arthritis, 
Diabetes, and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20205 
The specificity of the immune response is known to be a result of the presence of 
receptors for antigen on the surface of lymphocytes. For B lymphocytes the receptors 
are types of immunoglobulins specially designed to be membrane proteins, principally 
membrane IgM and membrane IgD (mIgM and mIgD). 1 From numerous tudies, 
first with rabbit lymphocytes (1), and later with human (2, 3) and mouse (4-6) 
lymphocytes, it has become clear that many of the supposed consequences of inter- 
action of B lymphocyte receptors with antigen could be induced by the interaction of 
such receptors with anti-receptor antibody. For the most part, this has involved the 
demonstration that anti-immunoglobulin (Ig) antibodies uch as anti-allotype or anti- 
isotype antibodies cause polyclonal B cell proliferation, usually demonstrated by 
uptake of radiolabeled thymidine. Earlier events in B cell activation, including 
increased protein and RNA synthesis and cell enlargement, have also been observed 
as a consequence of stimulation with anti-Ig antibodies (7). Furthermore, both 
Kishimoto and Ishizaka (8) and Parker et al. (9) have shown that anti-Ig-stimulated 
B cells may become antibody-secreting cells if soluble mediators present in the 
supernatant of spleen cells stimulated with antigen or concanavalin A (Con A) are 
added to these cultures. 
To better understand this model of the activation of B cells by antigen, it is 
important to determine whether all B cells respond to anti-Ig in each of these ways or 
whether only some subpopulations are capable of each response. Indeed, several 
studies now indicate that not all mouse splenic B ceils proliferate in response to anti- 
Ig antibody. For example, B cells from young mice (3-6 wk old) respond very well to 
lipopolysaccharide (LPS), but only poorly to anti-Ig antibodies, such as anti-/t (10). 
Similarly, cells with large amounts of mIgM or small amounts of mIgD give poor 
responses to anti-/t, as assessed by [3H]thymidine uptake (11). Even more striking is 
the inability of B cells from mice with the xid-determined immune defect o proliferate 
in response to this stimulus (10). These B cells do proliferate in response to LPS. 
Finally, the activation state of the B cell before removal from the animal has recently 
been shown to have a significant effect in determining which activation signals are 
* Supported by a fellowship from the Helen Hay Whitney Foundation. 
1 Abbreviations u ed in this paper: BDFI, (C57BL/6 × DBA/2)FI; CDFI, (CBA/N × DBA/2N)F~; Con A, 
concanavalin A; DCF~, (DBA/2N × CBA/N)F1; HBSS, Hanks' balanced salt solution; LPS, lipopolysac- 
eharide, mIgM, mIgD, membrane form of IgM or IgD; NP-40, Nonidet P-40; PBS, phosphate-buffered 
saline. 
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required in vitro to st imulate it to proliferate and differentiate into antibody-secreting 
cells (12). These observations indicate that both the degree of development and the 
state of activation of a B cell may influence its abil ity to respond to anti-st. In the 
current studies, we have studied the capacity of resting B cell populat ions to enter the 
G1 phase of the cell cycle in response to anti-st. In addit ion, we have directly measured 
the fraction of B cells that synthesize DNA in response to anti-/1 through the use of 
the quantitat ive fluorescent DNA stain propid ium iodide and by flow microfluo- 
rimetry. 
In both types of experiments, we used density-gradient centrifugation to separate 
resting and part ia l ly activated B cell populations and then cultured the resting B cells 
in the completely defined serum-free medium (Iscove's/F-12 medium) recently devel- 
oped by D. E. Mosier (13) from the original serum-free formulation of  Iscove and 
Melchers (14). The homogenous ize distr ibution of these cells made it possible to 
study size enlargement in response to anti-st. We found that virtual ly all small, dense 
B cells enlarged during the first 24 h of st imulation and that this enlargement was 
detectable within 1 h of addit ion of anti-st. In contrast, only ~60% of resting B cells 
synthesized DNA in response to anti-st. On the basis of these results, we conclude that 
anti-st stimulates all resting B cells to enter G1, but that only a fraction of these cells 
continue into S phase. 
Mater ia l s  and  Methods  
Animals. (C57BL/6J × DBA/2J)F~ (BDFI) female mice were obtained from The Jackson 
Laboratory, Bar Harbor, ME. (CBA/N × DBA/2N)F1 (CDFI) male mice and (DBA/2N × 
CBA/N)F~ (DCFa) male mice were obtained from the Division of Research Services, National 
Institutes of Health, Bethesda, MD. Mice were used between 2 and 4 mo of age. 
Reagents. Affinity-purified goat anti-/~ antibody was prepared essentially as previously 
described (6). The serum of goat 759 was the source of the anti-#. LPS w (Escherichia coli 
0111 :B4) prepared by the Westphal technique was obtained from Difco Laboratories, Detroit, 
MI. Fluorescent reagents used for analysis of cell surface markers (monoclonal nti-# antibodies 
Bet 1 and Bet 2 [15], monoclonal anti-8, 10.4.22 [16], monoclonal 14G82, and a fluoresceinated 
mouse anti-rat IgG) were kindly provided by Dr. John Kung, National Institutes of Health. 
Cell Preparation. Spleen cells were teased out of the spleen into Hanks' balanced salt solution 
(HBSS), washed, resuspended in HBSS containing a monoclonal anti-Thy-1.2 antibody (New 
England Nuclear, Boston, MA) and complement (guinea pig serum; 1:4, Flow Laboratories, 
Inc., Rockville, MD), and incubated at 37°C for 45 min to lyse the T cells. This treatment 
reduced the response of the cells to Con A to small percentage of that of untreated cells. 
Complement was removed by centrifugation and washing. The cells were then layered on top 
of a step gradient composed of 70, 60, and 50% Percoll (Pharmacia Fine Chemicals, Div. of 
Pharmacia, Inc. Piscataway, NJ), respectively. In typical experiments 2.5 ml of each solution 
was layered in a sterile capped culture tube (2057; Falcon Labware, Div. of Becton, Dickinson, 
and Co., Oxnard, CA). Percoll was made isoosmotic by the addition of 10× phosphate-buffered 
saline (PBS); this solution was considered to be "100% Percoll," as defined by Pharmacia. This 
solution was diluted to 70%, the pH was adjusted to 7.4 with HC1, and the osmotic strength, as 
measured by freezing point depression with an Osmette S (Precision Systems, Inc., Sudbury, 
MA), was adjusted to be between 0.310 and 0.320 osmolal. The 50 and 60% Pereoll solutions 
were obtained by diluting the 70% Pereoll solution with HBSS (without NaHCO3, adjusted to 
pH 7.2). Similar results were obtained when the Percoll was diluted with PBS, a condition 
which is closer to being isoosmotic for mouse cells (17). The gradient was chilled on ice for at 
least 15 min and then centrifuged at 2,300 g for 12 min at 5°C. In a Falcon 2057 tube, up to 
~10 s cells could be applied to the gradient without a decrease in the purity of the separated 
cells. The cells at each interface were collected from above with a pasteur pipette. Each fraction 
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was diluted at least twofold with HBSS, pelleted by centrifugation, and then washed twice 
with HBSS and once with culture medium. 
Cell Culture. Cells were cultured in the serum-free medium recently described by D. E. 
Mosier (Iscove's/F-12) (13). This medium is 50% Iscove's modified Dulbecco's medium (Gibco 
Laboratories, Grand Island Biological Co., Grand Island, NY), 50% Ham's F-12 medium 
(Gibco Laboratories) with the following additives: insulin (5 #g/ml; bovine crystalline zinc 
insulin; Gibco Laboratories), human transferrin (5 /tg/ml; Sigma Chemical Co., St. Louis, 
MO), progesterone (3 × 10 -8 M; Upjohn Laboratories, Kalamazoo, MI), 2-mercaptoethanol 
(5 × 10 -s M), gentamycin (50 gg/ml), and trace elements, MnCI2-4H20 (10 ng/titer), (NH4)s- 
MoTO~.4H20 (600 ng/liter), NiSO4.6H20 (70 ng/liter), H2SeO~ (1.9/~g/liter), NaSiOa-9 
H20 (71 /.tg/liter), SnC12 (50 ng/liter), NaaVO4-4 H20 (600 ng/liter), and CdSO4 (10.4 gg/ 
liter). For most studies 3 × 106 cells were cultured in 1 ml of medium in 16-mm Diam flat- 
bottomed tissue culture wells (3524; Costar, Data Packaging, Cambridge, MA). Similar results 
were obtained at cell densities ranging from 1 × 10 s to 5 x l0 s cells/well. Cultured cells were 
stimulated with goat anti-/t antibody (50 gg/ml), or with LPS (50 ~g/ml). Cells were harvested 
by gentle pipeting with a Pasteur pipette and all of the cells in the well were analyzed irectly. 
For determining the uptake of [3H]thymidine, cells were cultured at 2 × 10 b cells/well in flat- 
bottomed microtiter plates (3596; Costar). All cultures were incubated at 37°C in an atmosphere 
containing 5% CO2. When it was desirable to prevent cells from completing the cell cycle and 
going from M phase back to G1 phase, 25 ng/ml colcemid was added to the cultures 24 h after 
anti-g. This dose of colcemid was found not to increase cell death significantly, whereas higher 
concentrations did. 
Electronic Volume Analysis. The size distribution of B lymphocytes was determined by 
electronic analysis using a Coulter Counter (model ZB 1) and a Coulter Channelyzer L (model 
C-1000; Coulter Electronics, Hialeah, FL). The cells were suspended in PBS and analyzed with 
the following settings: amplification, 1/2, aperture current, 2; 100-ram aperture; lower thresh- 
old, 10; upper theshold, 100. Cell volume was determined by using microspheres from Coulter 
Electronics (Hialeah, FL) for calibration. Generally, 40,000 cells were analyzed per sample and 
plotted with full scale equal to 4,000. 
Flow Cytometric Analysis. The DNA content of individual cells was measured in a Coulter 
TPS- 1 Cell Sorter. Briefly, cells were centrifuged and stained with 50 gg/ml propidium iodide 
(Calbiochem-Behring Corp., American Hoechst Corp., LaJolla, CA) in 0.1% sodium citrate 
and 0.1% Nonidet P-40 (NP-40) detergent (18). The hypotonic solution caused cell lysis, but 
left the nuclei ntact, with propidium bound to DNA. Between 50,000 and 100,000 nuclei were 
analyzed for each sample. The amount of fluorescence emitted was proportional to the DNA 
content of individual nuclei. Cell cycle analysis was performed by computer assisted data 
analysis on the National Institutes of Health PDP-10 (Digital Equipment Corp., Marlboro, 
MA) by a planimetric ntegration method as previously described (19). This staining method 
has been criticized by Traganos et al. (20) because of a potential loss of cells in M phase. We 
have found that not to be a problem with the lymphocytes u ed in these xperiments based on 
the same two criteria used by Traganos et al. (20). That is, colcemid id cause a significant 
increase in the fraction of cells in G2 + M that does not occur if the nuclei from ceils blocked 
in M phase are especially fragile, and microscopic examination revealed that the nuclei from 
these cells do stay intact despite the lack of an obvious nuclear membrane. Nuclei with 
metaphase chromosomes were observed in equal proportions before hypotonic lysis and after 
flow cytofluorimetry, indicating that the analysis did not result in the disruption of M phase 
nuclei. 
Flow microfluorimetric analysis of cell surface fluorescence was performed by W. Leiserson 
(National Institutes of Health) using an FACS II (B-D FACS Systems, Mountain View, CA). 
Determination of the amounts of mlgM and of the antigen recognized by the monoclonal 
antibody 14G8 on individual cells was done by using rat monoclonal antibodies and a 
fluorescent-labeled mouse anti-rat IgG. In calculating the fraction of positively stained cells, 
the number of cells stained by the fluoresceinated anti-rat IgG alone was subtracted from the 
number of cells stained by the monoclonal ntibody followed by the fluoresceinated anti-rat 
IgG. The median fluorescence intensity was determined by calculating the median fluorescence 
for cells with more fluorescence than the negative control. This number was then normalized 
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to gain 16. The amount of IgD expressed on the cells was determined by staining directly with 
fluoresceinated monoclonal anti-8 (10.4.22). No correction was made to discount cells binding 
antibody nonspecifically in determining the fraction of cells staining positively with this reagent. 
The median fluorescence intensity for mIgD is not comparable to the intensity for the other 
two antigens, because the staining conditions were quite different. 
Results 
Separation of B Lymphocytes byDensity-Gradient Centrifugation. Splenic B lymphocytes 
are known to exist in several different states. One physical property in which they 
show variability is size. Melchers and his colleagues (12, 21 ) have recently emphasized 
that small, dense B lymphocytes have distinct activation requirements when compared 
with larger, blast-like cells and thus any study of B cell activation would be clearer if 
it employed cell populations initially separated on the basis of size and density. 
Fig. 1 presents a size analysis of splenic B lymphocytes. Such cells consisted of a 
major population corresponding in size to small, dense lymphocytes and found in a 
single peak. A substantial number of larger cells were also present. These did not 
clearly resolve into a separate peak. 
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FIG. 1. Cell volume distribution of density-fractionated B cells. Spleen cells from BDF1 mice were 
treated with anti-Thy-1.2 and complement and then separated on a Percoll step gradient. Fractions: 
low density (< 1.062), above 50% Percoll; intermediate density (1.062-1.074), 50-60% Percoll; dense 
(1.074-1.086), 60 70% Percoll. Cell volume was determined by electric resistance and calibrated 
with microspheres obtained from Coulter Electronics. 
TABLE I 
Distribution of B Cells Recovered from Density-Gradient Centrifugation 
Percent of re- 
Fraction Density covered cells 
Low density cells 1.062 16 ± 1%* 
Intermediate density B cells 1.062-1.074 24 ± 2% 
Small, dense B cells 1.074-1.086 60 ± 3% 
The results are the average of 10 experiments with BDF~ female mice. 
* Mean ± SEM. 
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Cells were separated into populat ions of distinctive density by gradient sedimen- 
tation using Percoll as the density medium. Percoll has an inherently low osmotic 
strength and gradient separations using it are rapid, versatile, reproducible, and 
inexpensive. Between 50 and 65% of the starting cells were typical ly recovered from 
the gradient described here. 
Cell populat ions eparated by Percoll density-gradient separation had distinct size 
distr ibutions as analyzed on a Coulter Counter. The dense fraction from Percoll 
separation (1.074-1.086 sp gr) was quite homogeneous in size (Fig. 1). Typical ly,  85- 
90% of these cells were in one sharp peak with a mean volume of 110 #m 3, conforming 
in size to the small cells found in the unseparated population. The cells of intermediate 
density (typically -25% of the recovered cells) had a reproducibly larger size as 
measured electrically (mean volume, 140 pro3). A similar difference between these 
two cell fractions was also observed by l ight-scatter analysis (data not shown). The 
cells of the lightest density fraction had a very heterogeneous size profile. The percent 
of cells recovered in each of these density ranges is shown in Table I. 
The representations of mIgM,  of mIgD, and of the membrane antigen recognized 
by 14G8 on the fractionated cells were determined by flow microfluorimetry. Results 
from representative experiments are presented in Table II. The cells appl ied to the 
Percoll gradient, having been treated with ant i -Thy- l .2  ant ibody and complement,  
were predominant ly  B cells. The least dense fraction was somewhat depleted of B 
cells in comparison to the unfract ionated cells. This is in agreement with the 
observations that this fraction was markedly enriched for phagocytic macrophages 
and for antigen-presenting cells (J. Mond, D. Longo, and L. Gl imcher, unpubl ished 
observations). The B cells that were present in this fraction had somewhat more 
mIgM, as judged by median fluorescence intensity, than did the B cells of higher 
TABLE II 
Membrane Markers of Cells in Distinct Density Fractions 
Cells* 
mIgM~: mIgD§ 14G8 antigenS: 
Median Median Percent Percent Percent of Percent of Median flu- fluores- fluores- 
of cells cence[[ of cells cence cells posi- B cells¶ orescence[[ 
positive intensity positive intensity rive positive intensity 
Unfractionated 76 520 75 670 41 53 170 
Low density 58 700 82** 490 43 74 430 
Intermediate d nsity 63 500 75** 420 45 71 250 
High density 80 300 85 960 38 (23)~::[: 47 (29):[:~ 60 (150):[::[: 
* Cells were obtained from DCFI~ mice. Similar esults were obtained with cells from BDFI mice. 
:~ Stained indirectly; the number of cells stained by mouse anti-rat IgG was subtracted from the number 
of cells stained indirectly to determine the percent positive cells. 
§ Stained by direct means; no correction for nonspecific staining was made. 
I[ Median fluorescence intensity of positive cells. The median fluorescence hannel, normalized to the 
same gain (gain 16), is shown. These numbers are directly comparable for mlgM and 14G8 antigen, 
because the same second stain was used. 
¶ Calculated by using the fraction of mIgM-positive cells stained in the same experiment as the number 
of B cells. 
** The frequency of IgD-bearing B cells in the low density and intermediate d nsity populations are 
probably substantially overestimated because of the binding of the directly fluoresceinated anti-lgD to 
the relatively frequent macrophages in these cell populations. 
:1::~ Values in parentheses are the numbers obtained if the extremely dull staining cells (<channel 60 at gain 
16) are not counted as positive. 
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Fro. 2. Time-course of DNA synthesis by density-fractionated B ceils stimulated with anti-p. (A) 
or LPS (B). B cells at 2 × 105 cells/well in Iscove's/F-12 medium were pulsed with [3tt]thymidine 
for 4 h at various times after the addition ofanti-/t or LPS to dense B cells or to intermediate d nsity 
B cells. 
density. Indeed, cells in the high density B cell fraction had considerably less mIgM 
than did the unseparated cells or either of the less dense populations. On the other 
hand, these high density cells had approximately twice the amount of mIgD as did B 
cells of the other two fractions. 
These fractionated B cells were even more distinctive with respect o their expession 
of the surface antigen recognized by the monoclonal ant ibody 14G8. Kung et al. have 
recently shown that this antigen is expressed only on a subset of B cells. 2 The two 
l ighter density fractions contained B cells of which two-thirds to three-fourths were 
positive with 14G8. These cells displayed relatively intense fluorescence, with the least 
dense B cells being brighter than the intermediate density B cells. In contrast, only 
about one-half  of the high density B cells were positive with 14G8, and many of the 
high density cells (~ 15%) expressed barely detectable amounts of the surface antigen. 
The median fluorescence of the brightest 25% of these cells was 150, still somewhat 
less than the median fluorescence for the intermediate density cells (250). 
Response of B Cells Separated by Density to LPS and Anti-tL B cell fractions separated 
by density were found to respond distinctively to anti-/t and to the B cell mitogen 
LPS. The high density B cells incorporated very small amounts of [aH]thymidine in 
the first 24 h after addit ion of either activator (Fig. 2). In contrast, the intermediate 
density cells mounted a vigorous response to LPS at this time. In many experiments, 
a small but detectable response to anti-/.t was observed at 24 h in cultures of 
intermediate density cells. Indeed, the response of the intermediate density cells to 
LPS was substantial as early as 12 h after addit ion of mitogen (data not shown). 
Furthermore, the intermediate density cells responded much more vigorously to LPS 
than to anti-/~, whereas in the dense B cell populat ion the levels of response were more 
similar. In some experiments the anti-# response of dense cells was greater than the 
LPS response, part icular ly when cells were cultured at 5 X 10 a per well. The relatively 
late onset of DNA synthesis in the dense cell populat ion suggests that it was mainly 
composed of B cells in the resting state. B cells of intermediate density, on the other 
2 Kung, J. T., S. O. Sharrow, A. Ahmed, R. Habberssett, and W, E. Paul,J. hnmunol. In press. 
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hand, were induced to enter S phase much sooner than were the dense B cells, 
suggesting that these B cells were not in the resting state. These cells may represent 
cells that had become partially activated in vivo, or immature B cells that had not yet 
attained the resting stage of B cell differentiation, or a combination of both of these 
types of cells. 
Size Analysis of Resting B Cells Stimulated with Anti-tt. The relatively homogeneous 
size of the dense B cells obtained by density-gradient centrifugation meant that the 
size changes accompanying the activation of these cells could be detected by volume 
analysis. Indeed, the Coulter Counter proved to be excellent for detecting size increases 
occurring in the course of B cell activation. B cells could be shown to be larger within 
1 h after addition of anti-/1 (Fig. 3). Furthermore, because ach cell's volume was 
recorded as part of the histogram, it proved possible to analyze the frequency of 
resting B cells that enlarged in response to anti-~. As can be seen in Fig. 3, virtually 
all small B cells increased their size upon stimulation with anti-/z. The enlargement of
the stimulated cells appeared to occur at similar rates for all cells in the population. 
That is to say, the histograms of the stimulated and the nonstimulated cells both 
showed single peaks, although with different mean volumes. No evidence for two 
subpopulations enlarging at different rates could be found. Two distinctive popula- 
tions would probably have resulted in a bimodal size distribution; this was not 
observed in any experiment among the >20 that were analyzed. 
These size enlargements appear to represent activation of the cells from the resting 
Go state into and through the Gx phase. This conclusion is supported by our 
preliminary results showing an increase in cellular RNA content of all dense B cells 
paralleling the size increase. Furthermore, the size enlargements correlate very well 
with the ability of these cells to enter S phase rapidly in response to a strong 
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Fro. 3. Cell volume distribution of dense B cells stimulated with anti-~. High density B cells 
prepared by density-gradient fractionation were cultured for various lengths of time in the presence 
of anti-~ and then subjected to cell volume analysis. Results of a typical experiment are shown. 
Ceils cultured without anti-/.t increased slightly in size soon after being put in Iscove's/F-12 medium, 
probably because the medium is hypotonic (0.290 osmolal). Subsequently, cell volume remained 
constant for at least 24 h. In this experiment anti-/.t was added to the cells at different imes before 
analysis, which was carried out on all samples at the same time. As a result, all cells were in culture 
for the same length of time. 
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Fio. 4. Increase in size of high density CDF]c~ B cells cultured with anti-g for 24 h. Cells were 
cultured with or without anti-~t for 24 h in Iscove's/F-12 medium containing 0.15 mg/ml bovine 
serum albumin. 
proliferative signal, such as that provided by LPS (A. L. DeFranco, E. S. Raveche, 
and W. E. Paul, manuscript in preparation). 
These results strongly suggested that all resting B ceils respond to anti-g similarly 
in the first 24 h of stimulation. Previous results, however, had indicated that there are 
B cell populations that do not proliferate in response to anti-g. One such population 
is the B cells from mice with the xid-determined B cell defect (10). These cells have 
been postulated to be similar to a subpopulation of normal B cells (22). Because of 
this, we examined the size changes of dense B lymphocytes prepared from CDF] male 
mice, which are hemizygous for the xid gene. These cells do not proliferate to a 
detectable degree in response to anti-/~. Nonetheless, many of these cells clearly enlarge 
upon exposure to anti-/~. Coulter analysis (Fig. 4) showed that many of the B 
lymphocytes from these mice enlarged in a manner comparable to that of B cells from 
phenotypically normal DCF1 male mice. 
Cell Cycle Analysis of B Cells Stimulated with Anti-g. As described in the Introduction 
and in the previous ection, certain B lymphocyte populations proliferate poorly or 
not at all to anti-/~. No direct measurements of the proportion of normal B lymphocytes 
that enter the cell cycle as a result of exposure to anti-g have been reported. To 
address this issue it was necessary to analyze cells for entrance into S phase at the 
single-cell evel. This was done by culturing high density B cells with anti-g for 
varying times, lysing the cells at low ionic strength, staining intact nuclei with 
propidium iodide, a fluorescent dye that binds to DNA and gives a fluorescent signal 
proportional to DNA content, and analyzing them by flow microfluorimetry. Typical 
histograms of cell number vs. DNA content are shown in Fig. 5. These data were 
analyzed by computer to obtain the fraction of ceils with a unit amount of DNA 
(cells in Go phase or GI phase), the fraction of cells with twice that amount of DNA 
(cells in G2 phase or M phase), and the fraction of cells with intermediate amounts of 
DNA (ceils in S phase). 
Determination of the fraction of cells in S phase or in G2 + M phases at various 
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Fro. 5. Cell cycle analysis of high density B cells stimulated with anti-#. Propidium iodide-stained 
nuclei from cells cultured for 48 h with or without anti-# and with or without colcemid were 
analyzed by flow mierofluorimetry. Colcemid (25 ng/ml), which blocks cells in mitosis, greatly 
increased the number of cells with twice the normal content of DNA. 
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FIG. 6. The fraction of high density B cells entering S phase in response to anti-#. Cells were 
cultured with or without colcemid, which prevented ividing ceils from leaving M phase. Analysis 
for DNA content, as described in Materials and Methods, was carried out at different imes after 
addition of anti-#. These data were processed to determine the fraction of cells in different phases 
of the cell cycle. Cells with the normal amount of DNA are in Go or Gt phases, cells with twice this 
amount of DNA are in G2 or M phases, and cells with intermediate amounts of DNA are in S phase. 
The fraction of cells that have responded at any given time is equal to the sum of the cells in S, G2, 
and M phases in the presence of colcemid, which prevented cells from returning to G1 phase. Values 
for S phase and G2 + M phases for cells cultured without co[cemid were corrected for the increase 
in cell numbers due to cell division. (A) BDF1 female, dense B cells. (B) CDFI male, dense B cells• 
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TABLE III 
Fraction of Cells Entering S Phase in Response to Anti-I~ and to LPS 
Source B cells fraction 
Percent of cells responding 
No mitogen With anti-/~ With LPS 
BDF~ High density 8.1 ± 1.1 (9)* 56.4 + 4.3 (7) 28.3 ± 9.9 (3) 
BDF1 Intermediate density 12.0 ± 2.8 (5) 40.5 + 3.7 (4) 33.0 _ 4.1 (4) 
DCF~ High density 6.0 (3) 35.5 ± 1.8 (3) 13.7 + 1.2 (3) 
DCF1 Intermediate density 9 (1) 30 (1) 27 (1) 
CDF1 High density 11.0 ± 1.9 (4) 12.0 ± 1.6 (4) 19.5 ± 1.5 (2) 
CDF1 Intermediate density 10.1 ± 2.0 (2) 11.0 ± 1.0 (2) 26 (1) 
* Mean ± SEM. Number of experiments in parentheses. 
times after addition of anti-# made it clear that the B cells activated to transit hrough 
the cell cycle did so in a relatively unsynehronized fashion (Fig. 6 A). An analysis of 
the fraction of cells entering S phase from such data would necessarily underestimate 
the true fraction because some cells would have already gone through S, G2, and M 
phases and returned to G1 phase before other cells had entered S phase for the first 
time. To solve this problem, an inhibitor of mitosis (colcemid; 25 ng/ml) was added 
to the cells after 24 h of stimulation, before any had reached M phase. This prevented 
cells from completing the cell cycle and returning to G1 phase. Thus, the fraction of 
cells entering S phase could be reliably determined simply by measuring the fraction 
of cells with greater than the unit amount of DNA (i.e., the number of cells in S plus 
the number in G2 + M). 
The response to anti-# of dense B cells from BDF~ mice is shown in Fig. 6 A. 
Typically, no cells entered S phase within the first 24 h after the addition of anti-#. 
By 30-36 h, there was a large number of cells in S phase, and by ~40 h, these cells 
were accumulating in M phase, since transit through that phase was blocked by 
colcemid. By ~48 h in culture, all of the cells that would enter S phase had already 
done so. The fraction of cells in S phase was the same with or without colcemid. This 
demonstrates that colcemid did not perturb the cells before the finish of S phase. 
Thus, eolcemid appears to be acting by blocking mitosis, as expected. 
In contrast, B cells from the spleen of CDF1 male mice (mice carrying an X 
chromosome with the defective xid allele) responded very poorly to anti-g (Fig. 6 B), 
in agreement with previous results obtained by uptake of [SH]thymidine (10). Typi- 
cally, the population of CDFa male cells incubated with anti-g contained only 1-2% 
more cells entering S phase than did the cells cultured without anti-g (Table III). 
This increase was not statistically significant. 
The average fraction of cells that entered S phase in response to anti-g and to LPS 
in a series of experiments i  shown in Table III. A large fraction of the cells prepared 
from BDF1 mice responded to anti-#. For the high density cell population, this 
represented ~48% of the cultured cells. Because B cells comprised ~80-85% of the 
high density cell population, nearly 60% of the B cells present were stimulated to 
enter S phase. By contrast, only 20% of the cells (25% of the B cells) in the high 
density population entered S phase in response to LPS. The intermediate density 
fraction also responded quite well to anti-p; -28% of all cells responded, or ~45% of 
the B cells. Approximately one-third of these B cells responded to LPS. The fraction 
of DCF~c~ B cells responsive to anti-g and to LPS was lower than the fraction of 
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responsive BDF1 cells, although it was still a substantial proportion. Cells from CDFad 
animals did not show statistically significant responses to anti-/~ but responded to LPS 
to the same extent as did the DCFld cells. 
Discussion 
We have examined the frequency of resting B lymphocytes that respond to anti-/~ 
antibody in serum-free medium. B cells were fractionated on the basis of density to 
obtain populations that were more homogeneous than those normally obtained from 
the spleen. It was found that cells with densities between 1.086 and 1.074 (70% and 
60% Percoll, respectively) are relatively uniform in size. Furthermore, these cells 
behaved like resting or Go state cells in that a long period of preparation, >24 h, was 
required before they entered S phase upon stimulation with LPS or anti-#. Based on 
the recovery of cells from the density gradient, these cells accounted for 60% of spleen 
cells previously treated with anti-Thy-1 and complement. In addition to these resting 
B cells, B cells of intermediate density were also recovered. This intermediate density 
population contained nonresting cells, as some of them entered S phase within 12 h 
after the addition of LPS. These two fractions were also seen to be phenotypically 
different when the cell surface xpression of mIgM, mIgD, and the antigen recognized 
by 14G8 were measured. The separation of these two physiologically distinct popu- 
lations of B cells made it possible to study the activation properties of the cells, 
especially the resting ceils, in more detail. 
Virtually all high density B cells were observed to enlarge after being incubated 
with anti-#. This enlargement was continuous and all B cells seemed to enlarge at 
roughly the same rate. There was no indication that there might be two different 
subpopulations with different rates of size increase. This enlargement probably reflects 
cell cycle advancement from the resting Go state to G1 phase of the active cell cycle 
and preparation for entering S phase. 
Although apparently all of the dense B cells enlarged upon stimulation with anti- 
/1, only -60% of these cells from BDF~ spleens and ~38% of these cells from DCF1 
spleens actually continued into S phase. Since 80-85% of the cells in these cultures 
were B cells, as defined by the presence of membrane IgM or IgD, these results uggest 
that -25% of the BDF1 cells and 45% of the DCF~ cells were B cells that did not enter 
S phase in response to anti-~t. These calculations assume that cell death in culture was 
evenly distributed between responding and nonresponding cells. While probably an 
oversimplification, this assumption is supported by several ines of reasoning. The 
survival of ceils for 2 d in Iscove's/F-12 medium was not markedly enhanced by the 
presence of anti-~. Thus, responding cells did not appear to be exempt from cell death 
in culture. Furthermore, the cell size distributions indicate that all B cells, both those 
that will enter S phase and those that will not, enlarged at approximately equal rates, 
at least for the first 24 h. Any possible differences in viability would presumably not 
have occurred until after that time, when nonresponding cells became blocked in their 
transit through the cell cycle. Finally, the fraction of cells with greater than the 
diploid content of DNA did not increase between 48 h of culture and 60 h of culture. 
If the nonresponding cells were dying more rapidly, this fraction would have continued 
to increase. Nevertheless, the assumption we have made is presumably not entirely 
accurate, so the true fraction of cells that enter S phase is possibly somewhat biased 
in one direction or the other. Even if the responding or the nonresponding cells 
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account for all of the cell death, which is the most extreme possibility, the main 
conclusion of this work would not be changed: that is, that all B cells are equally 
stimulated to enlarge, whereas ome ceils are stimulated to enter S phase and some 
cells are not. For example, cell death in the first 48 h was generally just over 50%. If  
only cells that would not enter S phase died, then the starting population would 
represent -25% responding cells and 75% nonresponding cells. Likewise, if only cells 
that would respond ied in culture, then the starting population would represent 75% 
responding cells and 25% nonresponding cells. In either case, there would still be a 
sizable fraction of cells entering S phase and a sizable fraction of cells not entering S 
phase. 
One interpretation of these results is that there are two functionally distinct subsets 
of B cells, one that can enter S phase in response to anti-/~ and one that cannot. The 
second B cell subset is clearly affected by the presence of anti-/~, since these cells 
enlarge during the first 24 h and thus may be considered to have entered G1 phase 
from the resting or Go state. These two subpopulations of B cells were not separated 
from one another by density fractionation, although small, resting B cells responded 
to anti-/~ in somewhat greater numbers than did intermediate density B ceils. 
A major fraction of B cells, probably ~60% in BDFx spleen populations, do respond 
to anti-# by proliferation. This is considerably higher than the proportion of B cells 
that respond to LPS. Previous estimates placed that number at 10-33% of the B cells, 
depending on the strain of mice used (23). Those results were obtained by limiting- 
dilution analysis in which cultures were scored as positive on the basis of the presence 
of antibody-secreting cells. In the experiments reported here, the fraction of cells 
responding to LPS by proliferation was measured and found to be similar to the 
previously reported fractions responding by antibody secretion. A similar result 
was also obtained by radioautography of ceils incubated with [3H]thymidine (24). It 
is striking that the percent of cells that enter S phase is not directly related to the 
amount of [3H]thymidine incorporated. Thus, LPS causes much greater uptake of 
[3H]thymidine by intermediate density cells than does anti-#, even though anti-/1 
causes more of these cells to enter S phase. This difference may be explained by the 
rate at which cells responding to anti-/~ and to LPS progress through S phase and/or 
by the frequency with which cells enter S phase for a second time. 
Despite the finding that only a fraction of the high density B cells entered S phase 
in response to anti-~, virtually all these cells undergo size enlargement. This suggests 
that a decision point exists in G1 phase and that only some B cells can be stimulated 
by anti-~t o "choose" to go on to S phase. B ceils from mice with the xid immune 
defect appear to exemplify those that enlarge hut do not enter S phase in response to 
anti-#. We should emphasize that those B cells from normal mice that enlarge but do 
not enter S phase in response to anti-/t are nonetheless capable of synthesizing DNA 
when appropriately stimulated because culturing dense BDF1 B ceils with anti-/x and 
LPS causes virtually all these cells to enter S phase (A. L. DeFranco, E. S. Raveche, 
and W. E. Paul, manuscript in preparation). 
It seems likely that some mediator(s) from T cells or macrophages, or perhaps the 
direct action of histocompatibility-restricted T cells may act similarly to LPS in 
inducing proliferation in those B cells that enlarge but do not enter S phase in 
response to anti-/~. Indeed, it seems plausible that these other stimulants may act at 
the later G1 decision point reached by cells stimulated by anti-/x. It is tempting to 
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suggest hat antigen, like anti-#, stimulates entry into Gx by specific cells and either 
causes them to enter S phase or renders them sensitive to appropriate mediators or 
direct T cells signals, which in turn control entry into S phase. 
Summary  
The frequency of murine B lymphocytes that respond to antibodies directed against 
membrane IgM was measured. These anti-# antibodies induced all, or almost all, 
resting B ceils to enlarge over the first 24 h of stimulation. This probably represents 
the transition from the resting state (Go) to active transit through the cell cycle. In 
contrast, only a fraction of these cells, ~60% for BDFa mice, continued through the 
cell cycle into S phase. This is consistent with previous experiments hat had suggested 
there were some types of B cells that did not proliferate in response to anti-#. The 
results presented here demonstrate hat many, perhaps all, of these nonresponding B 
ceils, both from normal mice and from mice with the xid defect, actually do respond 
to the presence of anti-# by going through early parts of the cell cycle. These cells 
appear to become blocked at some point before the beginning of S phase, perhaps 
requiring a signal from a T cell or a macrophage to continue through the cell cycle. 
Thus, the role of antigen may be to prepare all B cells for proliferation. Different 
subpopulations of B cells may then require different regulatory signals before actually 
proliferating or before differentiating into antibody-secreting cells. 
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